Hannah Stroud Burn, PharmD, MBA, IgCP: Renowned Pharmacist at Blue Sky Specialty Pharmacy
New York City, New York Jun 10, 2024 (Issuewire.com) - A highly trained pharmacist, Dr. Burn is the Clinical VP of Bleeding Disorders at Blue Sky Specialty Pharmacy in Mount Pleasant, South Carolina.
Throughout her academic career, she received her Doctor of Pharmacy degree from South University in 2019, before completing a Master of Business Administration (MBA) degree at the same educational venue in 2020.
Moreover, Dr. Burn recently received her IgNS-IgCP® certification, meeting nationally recognized standards to provide competent care to her Immunoglobulin patients through their journeys at Blue Sky Specialty Pharmacy.
Blue Sky Specialty Pharmacy is known for its dedication to delivering personalized care and specialized services to patients with complex healthcare needs. Dr. Burn's leadership will play a crucial role in advancing the pharmacy's mission to provide high-quality care and support to individuals living with bleeding disorders.
Learn More about Dr. Hannah Stroud Burn:
Through FindATopDoc.com, https://www.findatopdoc.com/doctor/85021324-Hannah-Stroud-Burn-Pharmacist
About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know-how to make informed decisions for you and your family.
Media Contact
Your Health Contact
More On 101broadcast ::
- Ibiza Enters a New Era of Boat Rentals and Charters with All-Inclusive Packages
- Best cloud mining service provider - DDB niner uses one-stop service to achieve passive income
- Lisa Chlapowski, Recognized by BestAgents.us as a 2025 Top Agent
- Empathy and Innovation: Dr. Ammar Mahmoud Featured in Exclusive Online Interview
- Emri Burnham, Recognized by BestAgents.us as a 2024 Top Agent
Source :Hannah Stroud Burn, PharmD, MBA, IgCP
This article was originally published by IssueWire. Read the original article here.